FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22351311000001103: Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73922601000001111 Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73922701000001118 Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Is a Rivastigmine 9.5mg/24hours transdermal patches 30 patch true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has AMP Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has specific active ingredient Rivastigmine true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start